Nektar Therapeutics News

Nektar Therapeutics (NKTR) First Quarter 2024 Earnings Overview

Yahoo Finance03:14

Nektar Therapeutics | 10-Q: Quarterly report

Futu News02:13 · Announcements

Nektar Therapeutics Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Financial Results.

Nektar Therapeutics Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Financial Results.

Benzinga00:48

Q1 2024 Nektar Therapeutics Earnings Call

Yahoo FinanceMay 10 22:35

Earnings Call Summary | Nektar Therapeutics(NKTR.US) Q1 2024 Earnings Conference

The following is a summary of the Nektar Therapeutics, Inc. (NKTR) Q1 2024 Earnings Call Transcript:Financial Performance:Nektar ended Q1 with a cash balance of $326 million and anticipates to close 2

Futu NewsMay 10 18:26 · Conference Call

Nektar Therapeutics, Inc. (NKTR) Q1 2024 Earnings Call Transcript

Nektar Therapeutics, Inc. (NKTR) Q1 2024 Earnings Call Transcript

Earnings Call TranscriptsMay 10 10:40

Nektar Therapeutics Q1 2024 GAAP EPS $(0.19) Beats $(0.20) Estimate, Sales $21.639M Beat $15.342M Estimate

Nektar Therapeutics (NASDAQ:NKTR) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.20) by 5 percent. This is a 73.97 percent increase over losses of $(0.

BenzingaMay 10 06:52

Nektar Therapeutics Q1 Loss Drops In Line With Estimates

RTTNewsMay 10 04:19

Nektar Therapeutics 1Q Rev $21.6M >NKTR

Nektar Therapeutics 1Q Rev $21.6M >NKTR

Dow JonesMay 10 04:15

Press Release: Nektar Therapeutics Reports First Quarter 2024 Financial Results

Nektar Therapeutics Reports First Quarter 2024 Financial Results PR Newswire SAN FRANCISCO, May 9, 2024 SAN FRANCISCO, May 9, 2024 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today reported

Dow JonesMay 10 04:15

Nektar Therapeutics Reports First Quarter 2024 Financial Results

SAN FRANCISCO, May 9, 2024 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the first quarter ended March 31, 2024. Cash and investments in marketable securi

NektarMay 9 12:00

Nektar to Announce Financial Results for the First Quarter 2024 on Thursday, May 9, 2024, After Close of U.S.-Based Financial Markets

SAN FRANCISCO, May 2, 2024 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the first quarter 2024 on Thursday, May 9, 2024, after the close of U.S.-based fin

NektarMay 2 12:00

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

GainersCyclacel Pharmaceuticals (NASDAQ:CYCC) stock moved upwards by 50.0% to $2.04 during Tuesday's pre-market session. The company's market cap stands at $2.6 million. GeneDx Hldgs (NASDAQ:WGS) shar

BenzingaApr 30 20:06

NK Cell Therapies Pipeline Report 2024: Insights on 80+ Companies and 100+ Pipeline Drugs, Including ALECSAT (CytoVac), NKTR-214/Bempegaldesleukin (Nektar Therapeutics), and Monalizumab (Innate Pharma)

Yahoo FinanceApr 26 16:12

Nektar Therapeutics Receives Letter That It Has Regained Compliance With Minimum Bid Price Requirement For Continued Listing On Nasdaq Capital Market - Filing

To regain compliance with the Minimum Bid Price Requirement, the Company's common stock was required to maintain a closing bid price of $1.00 per share or greater for at least 10 consecutive business

BenzingaApr 18 05:16

NKTR, VERU and EGIO Among Mid-day Movers

Seeking AlphaApr 12 00:55

Nektar (NKTR) Up 7.5% Since Last Earnings Report: Can It Continue?

Yahoo FinanceApr 3 23:30

Nektar Therapeutics Is Worried About This – Should You Be Worried Too?

TipRanksMar 7 14:00

Nektar Therapeutics Is Maintained at Hold by Jefferies

Nektar Therapeutics Is Maintained at Hold by Jefferies

Dow JonesMar 6 22:54

Jefferies Maintains Hold on Nektar Therapeutics, Raises Price Target to $1

Jefferies analyst Roger Song maintains Nektar Therapeutics (NASDAQ:NKTR) with a Hold and raises the price target from $0.5 to $1.

BenzingaMar 6 22:44